The Ever-Expanding Multiple Sclerosis Therapeutics

Video

Join Ahmed Obeidat, MD, PhD; Mitchell Freedman, MD; and Suma Shah, MD, for the second program of this monthly series as they discuss the evolution of therapeutics for the treatment of multiple sclerosis.

————————————

Panelists

  • Ahmed Obeidat, MD, PhD
    Assistant Professor, Department of Neurology, Neuroimmunology and Multiple Sclerosis; Director, Neuroimmunology and MS Fellowship Program, The Medical College of Wisconsin
  • Suma Shah, MD
    Director, MS & Neuroimmunology Fellowship, Duke University School of Medicine
  • S. Mitchell Freedman, MD FAAN
    Adjunct Professor of Neurology, University of North Carolina-Chapel Hill

Key Learning Objectives

  • Virtual patient visits during COVID-19 when treating MS
  • Changing barriers to treating MS
  • Evolution of monitoring safety and efficacy of therapy
  • The future of treating MS
Related Videos
Justin Moy
Diana Castro, MD
Amanda Peltier, MD
Marjan Gharagozloo, PhD
 Jeffrey Huang, PhD
Shiv Saidha, MBBCh
Julie Fiol, MSCN; Andreina Barnola, MD, MPH
© 2024 MJH Life Sciences

All rights reserved.